Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Biochemical Pharmacology
|
March 16, 2000
N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo
U Andersson, T D Butters, R A Dwek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1989
Activated platelets express IL-1 activity
C M Hawrylowicz, S A Santoro, F M Platt, et al.
The Journal of Biological Chemistry
|
March 18, 1994
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis
F M Platt, G R Neises, R A Dwek, et al.
The Journal of Rheumatology
|
August 1, 1993
Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis
I B Wilson, F M Platt, D A Isenberg, et al.
The Journal of Biological Chemistry
|
January 5, 1993
Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120
G B Karlsson, T D Butters, R A Dwek, et al.
Glycobiology
|
February 28, 2001
Imino sugar therapy for type 1 Gaucher disease
D A Priestman, F M Platt, R A Dwek, et al.
Journal of Virology
|
October 1, 1996
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure
P B Fischer, G B Karlsson, R A Dwek, et al.
Journal of Lipid Research
|
February 3, 2005
Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice
J L Kasperzyk, A d'Azzo, F M Platt, et al.
Analytical Biochemistry
|
August 10, 2000
High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples
H R Mellor, A Adam, F M Platt, et al.
Journal of Virology
|
October 1, 1996
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120
P B Fischer, G B Karlsson, T D Butters, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Biochemical Pharmacology
|
March 16, 2000
N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo
U Andersson, T D Butters, R A Dwek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1989
Activated platelets express IL-1 activity
C M Hawrylowicz, S A Santoro, F M Platt, et al.
The Journal of Biological Chemistry
|
March 18, 1994
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis
F M Platt, G R Neises, R A Dwek, et al.
The Journal of Rheumatology
|
August 1, 1993
Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis
I B Wilson, F M Platt, D A Isenberg, et al.
The Journal of Biological Chemistry
|
January 5, 1993
Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120
G B Karlsson, T D Butters, R A Dwek, et al.
Glycobiology
|
February 28, 2001
Imino sugar therapy for type 1 Gaucher disease
D A Priestman, F M Platt, R A Dwek, et al.
Journal of Virology
|
October 1, 1996
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure
P B Fischer, G B Karlsson, R A Dwek, et al.
Journal of Lipid Research
|
February 3, 2005
Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice
J L Kasperzyk, A d'Azzo, F M Platt, et al.
Analytical Biochemistry
|
August 10, 2000
High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples
H R Mellor, A Adam, F M Platt, et al.
Journal of Virology
|
October 1, 1996
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120
P B Fischer, G B Karlsson, T D Butters, et al.
Page
of 5